Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
Authors
Keywords
-
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-10
DOI
10.1016/j.apsb.2021.03.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Flos lonicerae flavonoids attenuate experimental ulcerative colitis in rats via suppression of NF-κB signaling pathway
- (2020) Daming Liu et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
- (2020) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Chartspiroton, a Tetracyclic Spiro-naphthoquinone Derivative from a Medicinal Plant Endophytic Streptomyces
- (2020) Huimin Zhao et al. ORGANIC LETTERS
- The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infection
- (2019) Xiangyu Chen et al. Cellular & Molecular Immunology
- Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease
- (2019) Xiaojuan Han et al. Autophagy
- Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances
- (2019) Sebastian Zundler et al. GUT
- CARD9+ microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment
- (2019) Rebecca A. Drummond et al. NATURE IMMUNOLOGY
- Histone H3 tail binds a unique sensing pocket in EZH2 to activate the PRC2 methyltransferase
- (2019) Krupa S. Jani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases
- (2019) Sruthi Vijaya Retnakumar et al. TRENDS IN MOLECULAR MEDICINE
- Targeting immune cell circuits and trafficking in inflammatory bowel disease
- (2019) Markus F. Neurath NATURE IMMUNOLOGY
- Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation
- (2019) Jie Zhou et al. Nature Communications
- Protective role of berberine on ulcerative colitis through modulating enteric glial cells–intestinal epithelial cells–immune cells interactions
- (2019) Heng Li et al. Acta Pharmaceutica Sinica B
- Glutathione peroxidase 8 negatively regulates caspase‐4/11 to protect against colitis
- (2019) Jye‐Lin Hsu et al. EMBO Molecular Medicine
- Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition
- (2019) Renan V. H. de Carvalho et al. Nature Communications
- Design, synthesis and biological evaluation of vincamine derivatives as potential pancreatic β-cells protective agents for the treatment of type 2 diabetes mellitus
- (2019) Junwei Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model
- (2019) Xiaoyu Fan et al. Acta Pharmaceutica Sinica B
- NLRP3: A promising therapeutic target for autoimmune diseases
- (2018) Hui-Hui Shen et al. AUTOIMMUNITY REVIEWS
- Sirtuin 3-induced macrophage autophagy in regulating NLRP3 inflammasome activation
- (2018) Penghao Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3
- (2018) Xingli Zhang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation
- (2018) Ming Zhao et al. Nature Communications
- Induction of multiple myeloma cancer stem cell apoptosis using conjugated anti-ABCG2 antibody with epirubicin-loaded microbubbles
- (2018) Fangfang Shi et al. Stem Cell Research & Therapy
- BCAP links IL-1R to the PI3K–mTOR pathway and regulates pathogenic Th17 cell differentiation
- (2018) Krystin Deason et al. JOURNAL OF EXPERIMENTAL MEDICINE
- REV-ERBα integrates colon clock with experimental colitis through regulation of NF-κB/NLRP3 axis
- (2018) Shuai Wang et al. Nature Communications
- The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel Disease
- (2018) Liming Mao et al. Frontiers in Immunology
- Ulcerative colitis
- (2017) Ryan Ungaro et al. LANCET
- Chemically induced mouse models of acute and chronic intestinal inflammation
- (2017) Stefan Wirtz et al. Nature Protocols
- Epithelial EZH2 serves as an epigenetic determinant in experimental colitis by inhibiting TNFα-mediated inflammation and apoptosis
- (2017) Yongfeng Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microbiota Normalization Reveals that Canonical Caspase-1 Activation Exacerbates Chemically Induced Intestinal Inflammation
- (2017) Adrian J. Błażejewski et al. Cell Reports
- Luteolin ameliorates dextran sulfate sodium-induced colitis in mice possibly through activation of the Nrf2 signaling pathway
- (2016) Yue Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages
- (2016) Jong-Seok Moon et al. NATURE MEDICINE
- The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3
- (2016) Hui Song et al. Nature Communications
- Control of Paneth Cell Fate, Intestinal Inflammation, and Tumorigenesis by PKCλ/ι
- (2016) Yuki Nakanishi et al. Cell Reports
- Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis
- (2015) Roni Nowarski et al. CELL
- Molecular mechanisms regulating NLRP3 inflammasome activation
- (2015) Eun-Kyeong Jo et al. Cellular & Molecular Immunology
- Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments
- (2015) Bruno Rafael Ramos de Mattos et al. MEDIATORS OF INFLAMMATION
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer
- (2014) Wenjie Guo et al. Autophagy
- Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis
- (2014) Cristina Mascaraque et al. PHARMACOLOGICAL RESEARCH
- Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
- (2013) Eunhee Kim et al. CANCER CELL
- Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine
- (2011) Xiaofei Shang et al. JOURNAL OF ETHNOPHARMACOLOGY
- The Nlrp3 inflammasome: contributions to intestinal homeostasis
- (2011) Md. Hasan Zaki et al. TRENDS IN IMMUNOLOGY
- Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
- (2010) C. Bauer et al. GUT
- Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
- (2009) T. H. Mogensen CLINICAL MICROBIOLOGY REVIEWS
- Autophagy: A lysosomal degradation pathway with a central role in health and disease
- (2008) Eeva-Liisa Eskelinen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started